Aurinia Pharmaceuticals Inc. (AUPH) vs Vera Therapeutics, Inc. (VERA)

A side-by-side comparison of Aurinia Pharmaceuticals Inc. and Vera Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AUPH vs VERA

growth of $100 · dividends reinvested · last 5y
AUPH +40.0% (+7.0%/yr)VERA +159.4% (+21.0%/yr)VERA compounded faster over this window
100200300400500Start $10020222023202420252026$140$259
AUPH VERA

AUPH vs VERA: by the numbers

  • •VERA is the larger company ($2.11B vs $2.02B market cap).
  • •AUPH is profitable (100.84% net margin) while VERA runs a net loss (0.00%).

Metrics side by side

Valuation

MetricAUPHVERA
P/E ratio6.85N/A
Forward P/E16.62N/A
P/S ratio6.48N/A
P/B ratio3.285.18
EV / EBITDA11.16N/A
FCF yield8.60%N/A

Profitability

MetricAUPHVERA
Gross margin90.36%0.00%
Operating margin37.06%0.00%
Net margin100.84%0.00%
ROE51.09%-98.56%
ROIC21.77%-85.78%

Growth (annualized)

MetricAUPHVERA
Revenue CAGR (5Y)40.17%N/A
Total return CAGR (5Y)-5.88%14.09%

Frequently asked

Is AUPH or VERA more profitable?
AUPH runs the higher net margin — AUPH at 100.84% versus VERA at 0.00%.
How have AUPH and VERA total returns compared?
Over the past 5 years, AUPH delivered -5.88% and VERA delivered 14.09% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.